Campbell & Co Investment Adviser’s Global Cord Blood Corporation CO Stock Holding History

Campbell & Co Investment Adviser’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14,500	Closed	-$56K	–	998
2022 Q1	$56K	Buy	+14,500	New	+$60.2K	0.02%	678
2021 Q2	–	Sell	-27,400	Closed	-$124K	–	769
2021 Q1	$124K	Buy	+27,400	New	+$119K	0.08%	388
2019 Q4	–	Sell	-17,699	Closed	-$86K	–	914
2019 Q3	$86K	Buy	+17,699	New	+$92.8K	0.03%	580

Other funds holding CO

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

Campbell & Co Investment Adviser's CO Position: Q2 2022 in Review

Campbell & Co Investment Adviser sold out of Global Cord Blood Corporation (CO) in Q2 2022, closing a stake of 14,500 shares — an estimated $56K sold.

Campbell & Co Investment Adviser first reported a position in CO in Q3 2019 and held it in 3 quarters. The position peaked at $124K in Q1 2021. 25 funds tracked by Wall St. Rank hold CO as of Q2 2022.

Campbell & Co Investment Adviser reported no remaining Global Cord Blood Corporation position as of Q2 2022 after selling out during the quarter.
Campbell & Co Investment Adviser sold 14,500 Global Cord Blood Corporation shares in Q2 2022, an estimated $56K.
Campbell & Co Investment Adviser first reported a position in Global Cord Blood Corporation in Q3 2019 and held it in 3 quarters.
Campbell & Co Investment Adviser's Global Cord Blood Corporation position peaked at $124K in Q1 2021.
25 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2022.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2022, filed 9 Aug 2022.